Companies / Biocept Inc
Biocept Inc
BIOCCIK 1044378
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 13, 2015 | Neff Edward A. Director | Buy Open-market buy | Common Stock | $50.0K | +40K +27.14% | 187,386 | low |
| Feb 13, 2015 | Hale David F Executive | Buy Open-market buy | Common Stock | $50.0K | +40K +73.30% | 94,570 | low |
| Feb 13, 2015 | Gerhardt Bruce Director | Buy Open-market buy | Common Stock | $25.0K | +20K +380.95% | 25,250 | low |
| Feb 13, 2015 | Nall Michael W. CEO | Buy Open-market buy | Common Stock | $15.0K | +12K | 12,000 | low |
| Feb 13, 2015 | Huebner Bruce a Director | Buy Open-market buy | Common Stock | $15.0K | +12K | 12,000 | low |
| Feb 13, 2015 | Royston Ivor Director | Buy Open-market buy | Common Stock | $15.0K | +12K +247.02% | 16,858 | low |
| Jun 1, 2015 | Singh Veena Executive | Buy Open-market buy | Common Stock | $9.9K | +3K +177.78% | 5,000 | low |
| May 29, 2015 | Singh Veena Executive | Buy Open-market buy | Common Stock | $5.5K | +2K | 1,800 | low |